# CERTIAURA BUILD 0005 — RETATRUTIDE EVIDENCE VERIFICATION & SAFETY EXPANSION

**Build:** 0005  
**Version:** 0.5.0  
**Date:** 2026-07-14

## Purpose

Strengthen the Retatrutide evidence layer by:

- upgrading source-verification status where a primary publication can now be identified;
- converting recurring safety domains into formal Safety Knowledge System assets;
- converting evidence-supported monitoring domains into formal Monitoring Knowledge System assets;
- preserving provisional late-stage safety signals as provisional;
- adding an evidence-maturity assessment without inventing a misleading completeness percentage.

## Key verification change

`CERT-EKS-000012` is upgraded from:

**Tier C evidence lead — primary source pending**

to:

**Primary Lancet publication identified — direct full-text extraction pending**

Primary article record:

- Journal: The Lancet
- PII: `S0140-6736(26)00967-0`
- URL: `https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2826%2900967-0/fulltext`

Direct automated retrieval was access-blocked, so line-by-line primary extraction remains open.

## New Safety Knowledge System assets

- `CERT-SKS-000001` — Gastrointestinal Adverse Events
- `CERT-SKS-000002` — Heart Rate Increase
- `CERT-SKS-000003` — Dysesthesia / Abnormal Skin Sensation
- `CERT-SKS-000004` — Treatment Discontinuation and Tolerability
- `CERT-SKS-000005` — Hypoglycaemia Context

## New Monitoring Knowledge System assets

- `CERT-MKS-000006` — Heart Rate
- `CERT-MKS-000007` — Gastrointestinal Tolerability
- `CERT-MKS-000008` — Dysesthesia / Abnormal Skin Sensation Monitoring
- `CERT-MKS-000009` — Treatment Discontinuation
- `CERT-MKS-000010` — Body Composition

## Important

- Safety assets summarise evidence; they are not prescribing instructions.
- Provisional late-stage signals remain explicitly source-tiered.
- No Platinum certification is claimed.

Suggested commit message:

`Add Certiaura Build 0005 evidence verification and safety expansion`
